Rivaroxaban Versus Enoxaparin for Prophylaxis of Venous Thromboembolism in Bariatric Surgery
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age20-60
SponsorAlexandria University
About this trial
Rivaroxaban versus enoxaparin for prophylaxis of venous thromboembolism in morbidly obese patients undergoing bariatric surgery: An open\_label randomized controlled trial
Eligibility criteria
Qualifiers
Age: 20-60 years, both sexes.
ASA physical status class I to III.
BMI 35-50 kg/m²
Disqualifiers
Severe cardiac disorder
chronic renal failure
liver cirrhosis
major psychological disorder
Trial design
Treatments tested in this trial
- Enoxaparin
- rivaroxaban
Treatment groups
162 Participants
are divided into 2 treatment groupsLocations
1Alexandria University Alexandria Egypt
Sponsors and collaborators
Alexandria University
Lead sponsor
Source ClinicalTrials.gov